● Neutral for Indian equities

FDA upgrades Vitruvias Therapeutics recall: Superpotent thyroid tablets could trigger heart problems; who is at risk?

1 source · first seen 22:22 24 Sept · updated 22:22 24 Sept

The brief

Written from 1 report · check the source before you trade

FDA classified Vitruvias Therapeutics’ thyroid-tablet recall as Class I over potential superpotency
Superpotent tablets could cause serious health problems, including heart problems

Pick a tag to see all its stories

1 report · earliest 22:22